Decitabine FDA approval date

The FDA approved Decitabine on 2 May 2006.

FDA approval date
2 May 2006

Drug identity checked against registry records

Included trials

TrialSponsorPhaseStatusPrimary completion
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2NCT04229979Sellas Life Sciences GroupPhase 3Active not recruiting2025-12Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2006-05-02DayDecitabineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021790", "applicant_as_listed_by_fda": "OTSUKA", "brand_names": ["DACOGEN"], "active_ingredients": ["DECITABINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060502", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026